From Volume to Value: How Ipca Laboratories Scaled Compliant Lab Operations with BIOVIA ONE Lab

Ipca Laboratories Limited (Ipca) is a global pharmaceutical manufacturer operating 34 manufacturing sites and 8 R&D laboratories, managing over 15,000 API batches and 20,000 formulation batches annually.

As testing volumes expanded across global sites, Ipca’s reliance on manual, paper-based workflows created significant operational bottlenecks in sample registration, data entry, and Certificate of Analysis (COA) preparation. Managing high-volume QC operations across multiple locations made it increasingly difficult to scale while maintaining data integrity, traceability, and inspection readiness.

To support scalable growth, Ipca selected BIOVIA ONE Lab to transition to a standardized, cloud-based digital laboratory environment.

By deploying structured digital workflows, automated COA generation, and review-by-exception, Ipca achieved:

• 2.5x Increase in laboratory productivity
• 75% Reduction in lab testing cycle time
• 90% Decrease in manual data entry errors
• 100% Sustained regulatory compliance rate across sites

Download the full case study to discover how Ipca unified their sites onto a single digital platform, cut review times and operational expense by 40%, and built a scalable foundation for global lab expansion.